Scand J Gastroenterol 31: 665-670, 1996
For individuals who tolerate the medication well and may need additional support in managing blood glucose, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or a maximum of 15 mg weekly, depending on the healthcare providers recommendations
This article explains what the clinical trial data reveal about dosing, safety considerations, and side effects, and clarifies the current regulatory status helping readers understand what retatrutide is, where the research stands, and how to access approved weight management treatments in the UK
Thankfully, your diet and daily habits can influence the release of GLP-1 hormone, and this is backed by research
Clinical trial data (Jastreboff et al., NEJM 2023